Allison O. Dumitriu Carcoana
Papers
1
Total Citations
2
H-Index
1
About
Dr. Allison O. Dumitriu Carcoana is a surgical researcher whose work focuses on refining prognostic markers and improving outcomes in thoracic oncology, particularly for lung cancer patients undergoing minimally invasive procedures. Her key research areas include perioperative risk stratification, the utility of novel biomarkers like the blood urea nitrogen to serum albumin ratio (BAR), and the optimization of robotic-assisted pulmonary lobectomy outcomes. Her most cited study, published in 2023, critically examined whether a high preoperative BAR predicts worse outcomes following robotic-assisted pulmonary lobectomy for lung cancer. This work challenges emerging assumptions about BAR as a universal prognostic tool, demonstrating that it does not reliably forecast adverse results in this specific surgical context—a finding that helps refine clinical decision-making and prevent unnecessary risk categorization. With 2 citations to date, this paper contributes to a growing evidence base that calls for nuanced application of biomarkers in surgical oncology. Dr. Dumitriu Carcoana’s research is notable for its direct clinical relevance, offering surgeons and oncologists clearer guidance on which patients truly require heightened perioperative vigilance, thereby advancing the safety and precision of robotic lung cancer surgery.
Research Focus
Key Achievements
Top Papers
- 1